704-750-0409
Patient Portal
Every year, new studies emerge that help us better understand the biological underpinnings of mental health and developmental disorders. Some of them pass quickly through the headlines, but others represent a genuine step forward. Two areas that I believe fall into that second category are the FRAT Test (Folate Receptor Autoantibody Test) and the use of leucovorin (folinic acid) in autism spectrum disorder.
These are topics I’ve been following — and using — in my own practice for quite some time, and I want to share what they mean for families navigating autism care today.
Folate (vitamin B9) plays a critical role in brain development and function. For some individuals, the body produces antibodies that block folate from reaching the brain, a condition known as cerebral folate deficiency. The FRAT Test helps identify these folate receptor autoantibodies so we can better understand whether this biological mechanism might be contributing to a patient’s symptoms.
When a patient tests positive, that information can change the direction of treatment. It gives us the chance to address something that’s happening beneath the surface — something that might otherwise go unnoticed.
In patients with autism spectrum disorder (ASD), identifying a folate-transport problem can be particularly meaningful, as it may relate to communication, attention, or behavioral differences.
Leucovorin, also known as folinic acid, is a form of folate that bypasses the receptor that these antibodies interfere with. In simple terms, it helps get folate into the brain even when the usual route is blocked.
Recently, the FDA has taken steps to acknowledge leucovorin’s potential benefits in individuals with cerebral folate deficiency and related symptoms seen in some forms of autism. Several clinical studies have shown measurable improvements in language, social interaction, and overall functioning when leucovorin is used appropriately under medical supervision.
I’ve been aware of these benefits for years, long before the FDA’s most recent announcements. In fact, I’ve been using leucovorin in select cases where testing and clinical context supported its use. While it isn’t a one-size-fits-all solution, for the right patient it can make a real difference.
When I evaluate a child, adolescent, or adult with developmental or behavioral concerns, I try to look at the full picture — genetics, nutrition, sleep, emotional health, family dynamics, and lab data. The FRAT Test is one more piece of that larger puzzle.
If the results show a folate receptor issue, leucovorin can sometimes become part of the treatment plan. I combine it with other evidence-based approaches — therapy, behavioral support, medication when appropriate, and nutritional care — to create an individualized plan that fits the person, not just the diagnosis.
That balance between science and humanity is central to how I practice. I don’t believe in chasing trends, but I do believe in staying curious and integrating new information when it can help people feel and function better.
For many families, getting a diagnosis of autism is both a relief and a new beginning. It answers some questions but raises a dozen more: What now? What else can we do?
Exploring the biological contributors — like folate receptor autoantibodies — gives us one more way to bring clarity, and sometimes hope, to a situation that can feel uncertain. Not every patient will benefit from leucovorin, but for those who do, the improvements can be meaningful.
That’s why I continue to explore these pathways — because understanding the biology of the brain helps me better understand the people I care for.
If you’ve heard about leucovorin or FRAT testing and wonder whether it might be helpful for you or your child, I’d be happy to talk through it with you. Together, we can explore whether these tools might offer new insight — and create a plan that feels both hopeful and grounded in science.
Start with a free 15-minute consultation to see how we can help.
Schedule your 15 minute no-cost consultation